Experimental findings suggest that oligomeric forms of the amyloid  protein (A) play a critical role in Alzheimer's disease. Thus, elucidating their structure and the mechanisms of their formation is critical for developing therapeutic agents. We use discrete molecular dynamics simulations and a four-bead protein model to study oligomerization of two predominant alloforms, A40 and A42, at the atomic level. The four-bead model incorporates backbone hydrogen-bond interactions and amino acid-specific interactions mediated through hydrophobic and hydrophilic elements of the side chains. During the simulations we observe monomer folding and aggregation of monomers into oligomers of variable sizes. A40 forms significantly more dimers than A42, whereas pentamers are significantly more abundant in A42 relative to A40. Structure analysis reveals a turn centered at Gly-37-Gly-38 that is present in a folded A42 monomer but not in a folded A40 monomer and is associated with the first contacts that form during monomer folding. Our results suggest that this turn plays an important role in A42 pentamer formation. A pentamers have a globular structure comprising hydrophobic residues within the pentamer's core and hydrophilic N-terminal residues at the surface of the pentamer. The N termini of A40 pentamers are more spatially restricted than A42 pentamers. A40 pentamers form a -strand structure involving Ala-2-Phe-4, which is absent in A42 pentamers. These structural differences imply a different degree of hydrophobic core exposure between pentamers of the two alloforms, with the hydrophobic core of the A42 pentamer being more exposed and thus more prone to form larger oligomers.Alzheimer's disease ͉ discrete molecular dynamics ͉ four-bead protein model ͉ oligomer formation T he amyloid -protein (A) has been strongly linked to the etiology and pathogenesis of Alzheimer's disease (AD). A assembles into amyloid fibrils and smaller, oligomeric assemblies. Experimental and clinical findings suggest that protofibrillar intermediates (1-3) and oligomeric forms (4-13) of A may be particularly important. If so, elucidating the structures of these A oligomers and the mechanisms of their formation is critical for developing therapeutic agents. Unlike proteins with stable folds, A oligomers are metastable. They cannot be crystallized for x-ray diffraction studies nor can they be easily studied by using solutionphase NMR. Monomers and oligomers are also in dynamic equilibrium, which makes the study of pure populations of conformers using classical biophysical techniques difficult.A exists in two predominant forms, 40 (A40) or 42 (A42) amino acids in length. Of the two, A42 is associated most strongly with an increased risk for AD, is more neurotoxic, and forms fibrils significantly faster. Recent experiments demonstrated that A oligomers can be covalently cross-linked, and therefore stabilized, by using the technique of photo-induced cross-linking of unmodified proteins (PICUP) (14). During PICUP coupled with si...